Formerly known as Quantitative Radiology Solutions
QRS CEO Joe Camaratta presented the company’s fund-raising opportunity at Mid-Atlantic Diamond Ventures Fall Forum. Mid-Atlantic Diamond Ventures (MADV) is an independent organization that assists emerging, technology-based companies in their effort to build sustainable businesses by better positioning their firms for funding while increasing value at an early and crucial stage. To date, 386 Mid-Atlantic companies have… Read More
QRS presented its first poster at the American Association of Physics on Aug. 2, 2017. The poster addressed evaluation of segmentation methods as a function of the quality of input images. Learn More… Read More
QRS was selected as one of the Top 30 Life Sciences Startups in the RESI Innovation Challenge. From a pool of approximately 100 applicants, the LSN Scientific Review Team has selected QRS among a diverse group of life science startups: three healthcare IT, three diagnostic, thirteen therapeutic, and eleven medical device companies. QRS will showcase in… Read More
QRS will be presenting its findings on “Evaluation of segmentation methods as a function of the quality of input images” at the American Association of Physicists in Medicine (AAPM) conference in Denver starting 7/30. Additionally, the company will “A high-performance software system for auto contouring head and neck anatomy in adaptive radiation therapy” and “Knowledge-based… Read More
QRS was awarded “Best on INVEST Pitch Perfect” in the Health IT category by MedCity News in an event in Chicago last week. The MedCity INVEST Pitch Perfect Contest hosted promising startup companies, offering innovative approaches or trying to solve some of the biggest problems in healthcare. Participating biopharma, diagnostics, medical device, and digital health startups… Read More
Joe Camaratta, the CEO of Quantitative Radiology Solutions, was awarded the PCI Ventures CEO of the Year Award for 2016. Under Joe’s leadership, the company has secured multiple commercialization grants from NIH and NSF as well as funding from Phase I Ventures to further develop its medical imaging software to aid in radiation therapy planning.… Read More
Quantitative Radiology Solutions has raised $213,000 from Phase 1 Ventures to accelerate commercialization of its Automatic Anatomy Recognition (AAR) software in radiation treatment planning. Phase 1 Ventures is an accelerator program at University City Science Center that provides early stage businesses with funding and expertise to support commercialization of innovative technologies in healthcare and other… Read More
Quantitative Radiology Solutions was awarded a Phase I STTR grant for “Automated object contouring methods and software for thoracic radiotherapy planning.” The grant will allow the company to continue development of its Automatic Anatomy Recognition (AAR) in radiation oncology. The research will be conducted in collaboration with University of Pennsylvania.… Read More
Quantitative Radiology Solutions was awarded a Phase 1 STTR grant for “Automated object contouring methods and software for head and neck radiotherapy planning.” The grant will allow the company to continue development of its Automatic Anatomy Recognition (AAR) in radiation oncology. The research will be conducted in collaboration with University of Pennsylvania.… Read More
Quantitative Radiology Solutions presented at IMPACT 2015 Capital Conference. The company was featured in the Early Stage track and developed contacts with potential investors and technology partners. For more information, click on the link.… Read More
Copyright © 2021 Quantaras. All rights reserved.